Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 30;39(1):BSR20180773.
doi: 10.1042/BSR20180773. Print 2019 Jan 31.

The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders

Affiliations
Review

The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders

Yang Du et al. Biosci Rep. .

Abstract

Inhibitor of growth 4 (ING4), a member of the ING family discovered in 2003, has been shown to act as a tumor suppressor and is frequently down-regulated in various human cancers. Numerous published in vivo and in vitro studies have shown that ING4 is responsible for important cancer hallmarks such as pathologic cell cycle arrest, apoptosis, autophagy, contact inhibition, and hypoxic adaptation, and also affects tumor angiogenesis, invasion, and metastasis. These characteristics are typically associated with regulation through chromatin acetylation by binding histone H3 trimethylated at lysine 4 (H3K4me3) and through transcriptional activity of transcription factor P53 and NF-κB. In addition, emerging evidence has indicated that abnormalities in ING4 expression and function play key roles in non-neoplastic disorders. Here, we provide an overview of ING4-modulated chromosome remodeling and transcriptional function, as well as the functional consequences of different genetic variants. We also present the current understanding concerning the role of ING4 in the development of neoplastic and non-neoplastic diseases. These studies offer inspiration for pursuing novel therapeutics for various cancers.

Keywords: aberrant expression status; chromosome remodeling; gene therapy; inhibitor of growth 4; mechanisms; non-neoplastic diseases.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1
Figure 1. The known mechanisms of ING4 transcriptional regulation and its suppression of tumor growth and progression through downstream targets to modulate cellular events

Similar articles

Cited by

References

    1. Wang Y., Xue D., Li Y., Pan X., Zhang X., Kuang B.. et al. (2016) The long noncoding RNA MALAT-1 is a novel biomarker in various cancers: a meta-analysis based on the GEO database and literature. J. Cancer 7, 991–1001 10.7150/jca.1466310.7150/jca.14663 - DOI - PMC - PubMed
    1. Russell M., Berardi P., Gong W. and Riabowol K. (2006) Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis. Exp. Cell Res. 312, 951–961 10.1016/j.yexcr.2006.01.02010.1016/j.yexcr.2006.01.020 - DOI - PubMed
    1. Shiseki M., Nagashima M., Pedeux R.M., Kitahama-Shiseki M., Miura K., Okamura S.. et al. (2003) p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res. 63, 2373–2378 - PubMed
    1. Gunduz M., Nagatsuka H., Demircan K., Gunduz E., Cengiz B., Ouchida M.. et al. (2005) Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 356, 109–117 10.1016/j.gene.2005.02.01410.1016/j.gene.2005.02.014 - DOI - PubMed
    1. Kim S., Chin K., Gray J.W. and Bishop J.M. (2004) A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc. Natl. Acad. Sci. U.S.A. 101, 16251–16256 10.1073/pnas.040715810110.1073/pnas.0407158101 - DOI - PMC - PubMed

Publication types

MeSH terms